Depressive symptoms in youth before and during the COVID-19 pandemic: longitudinal investigation of patterns dependent on age, sex, and family history of mental illness.

COVID-19 adolescent medicine depression mental illness parental mental health psychiatry youth at-risk

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
06 Sep 2023
Historique:
medline: 6 9 2023
pubmed: 6 9 2023
entrez: 6 9 2023
Statut: aheadofprint

Résumé

Cross-sectional studies report high levels of depressive symptoms during the COVID-19 pandemic, especially in youth and females. However, longitudinal research comparing depressive symptoms before and during the pandemic is lacking. Little is known about how the pandemic affected individuals with familial history of mental illness. The present study examines the impact of the pandemic on youth depressive symptoms, including offspring of parents with major mood and psychotic disorders. Between March 2018 and February 2020, we measured depressive symptoms in 412 youth aged 5-25 years. We measured depressive symptoms again in 371 (90%) of these youth between April 2020 and May 2022. Two thirds (249) participants had a biological parent with a major mood or psychotic disorder. We tested the effect of the pandemic by comparing depression symptoms before and after March 2020. We examined age, sex, and family history as potential moderators. We found an overall small increase in youth depressive symptoms ( Our results provide reassurance about the wellbeing of children of parents with mental illness during a period of restricted access to resources outside the family. Rather than increasing symptoms in established risk groups, the pandemic led to a redistribution of depression burden towards segments of the youth population that were previously considered to be low-risk.

Sections du résumé

BACKGROUND BACKGROUND
Cross-sectional studies report high levels of depressive symptoms during the COVID-19 pandemic, especially in youth and females. However, longitudinal research comparing depressive symptoms before and during the pandemic is lacking. Little is known about how the pandemic affected individuals with familial history of mental illness. The present study examines the impact of the pandemic on youth depressive symptoms, including offspring of parents with major mood and psychotic disorders.
METHODS METHODS
Between March 2018 and February 2020, we measured depressive symptoms in 412 youth aged 5-25 years. We measured depressive symptoms again in 371 (90%) of these youth between April 2020 and May 2022. Two thirds (249) participants had a biological parent with a major mood or psychotic disorder. We tested the effect of the pandemic by comparing depression symptoms before and after March 2020. We examined age, sex, and family history as potential moderators.
RESULTS RESULTS
We found an overall small increase in youth depressive symptoms (
CONCLUSIONS CONCLUSIONS
Our results provide reassurance about the wellbeing of children of parents with mental illness during a period of restricted access to resources outside the family. Rather than increasing symptoms in established risk groups, the pandemic led to a redistribution of depression burden towards segments of the youth population that were previously considered to be low-risk.

Identifiants

pubmed: 37671680
doi: 10.1017/S003329172300257X
pii: S003329172300257X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Subventions

Organisme : Nova Scotia Health Research Foundation
ID : 275319, 1716 and 353892
Organisme : Dalhousie Medical Research Foundation
ID : Sutton Family Fund - Graduate Award
Organisme : Canada Research Chairs
ID : 231397, and 950-233141
Organisme : Research Nova Scotia
ID : RNS-PRG-010
Organisme : Mach-Gaensslen Foundation of Canada
ID : Research in Medicine Studentship

Auteurs

Emily Howes Vallis (E)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Meg Stephens (M)

Nova Scotia Health Authority, Halifax, NS, Canada.

Briana Ross (B)

Nova Scotia Health Authority, Halifax, NS, Canada.

Sheri Rempel (S)

Nova Scotia Health Authority, Halifax, NS, Canada.

Cynthia Howard (C)

Nova Scotia Health Authority, Halifax, NS, Canada.

Dara Liu (D)

Nova Scotia Health Authority, Halifax, NS, Canada.

Kelsey Villars (K)

Nova Scotia Health Authority, Halifax, NS, Canada.

Raegan Mazurka (R)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Jill Cumby (J)

Nova Scotia Health Authority, Halifax, NS, Canada.

Martin Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Barbara Pavlova (B)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Rudolf Uher (R)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Nova Scotia Health Authority, Halifax, NS, Canada.

Classifications MeSH